OSTEOPOROSIS: IS IT TIME TO TREAT-TO-TARGET

被引：0

作者：

Lewiecki, M. ^{[1
]}

机构：

[1] Univ New Mexico, Albuquerque, NM 87131 USA

来源：

OSTEOPOROSIS INTERNATIONAL | 2014年 / 25卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

IS5

引用

页码：S660 / S660

页数：1

共 50 条

[41] 'Treat-to-target' with allopurinol is feasible in patients with gout
Shreeya Nanda
Nature Reviews Rheumatology, 2011, 7 (1) : 3 - 3
[42] Challenges in Implementing Treat-to-Target Strategies in Rheumatology
Ford, Julia A.
Solomon, Daniel H.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2019, 45 (01) : 101 - +
[43] Treat-to-Target Strategy for Fibromyalgia: Opening the Dialogue
Haeuser, Winfried
Clauw, Daniel J.
Fitzcharles, Mary-Ann
ARTHRITIS CARE & RESEARCH, 2017, 69 (04) : 462 - 466
[44] What is the optimal target for treat-to-target strategies in rheumatoid arthritis?
Bergstra, Sytske Anne
Allaart, Cornelia F.
CURRENT OPINION IN RHEUMATOLOGY, 2018, 30 (03) : 282 - 287
[45] Treat-to-Target Strategies in Rheumatoid Arthritis Reply
Moller-Bisgaard, Signe
Ostergaard, Mikkel
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (01): : 83 - 84
[46] Treat-to-target urate lowering therapy for gout
Thorley, Jennifer
LANCET RHEUMATOLOGY, 2020, 2 (09): : E526 - E526
[47] Treat-to-target in rheumatoid arthritis - are we there yet?
van Vollenhoven, Ronald
NATURE REVIEWS RHEUMATOLOGY, 2019, 15 (03) : 180 - 186
[48] Issues in implementing a treat-to-target approach in RA
Marc D. Cohen
Edward C. Keystone
Nature Reviews Rheumatology, 2013, 9 : 137 - 138
[49] Treat-to-Target – Beteiligung der PatientenTreat to target—participation of the patient
K. Cattelaens
S. Schewe
F. Schuch
Zeitschrift für Rheumatologie, 2019, 78 : 416 - 421
[50] Treat-to-target or treat-to-dissolve strategy to improve gout treatment
Richette, Pascal
Dalbeth, Nicola
NATURE REVIEWS RHEUMATOLOGY, 2024, 20 (07) : 393 - 394

← 1 2 3 4 5 →